戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              Coats define the composition of carriers budding from or
2                                              Coats plus (CP) can be caused by mutations in the CTC1 c
3                                              Coats plus is a highly pleiotropic disorder particularly
4                                              Coats' disease is characterized by abnormal retinal vasc
5 patients who underwent treatment for stage 2 Coats' disease in a tertiary center in the United Kingdo
6 e intraoperative FA in children with stage 2 Coats' disease led to good anatomic outcome, with preser
7  (n = 15, 22%), pars planitis (n = 14, 21%), Coats disease (n = 11, 16%), previous retinal detachment
8 n 1 year were most likely to have PFV (49%), Coats' disease (20%), or vitreous hemorrhage (7%); those
9 an important pathophysiological link between Coats plus and the clinically related telomere disorders
10 ve vitreoretinopathy (FEVR), Norrie disease, Coats' disease, bilateral persistent fetal vasculature,
11  older than 5 years were most likely to have Coats' disease (57%), toxocariasis (8%), or FEVR (6%).
12 2 to 5 years of age were most likely to have Coats' disease (61%), toxocariasis (8%), or PFV (7%); an
13 he most common pseudoretinoblastomas include Coats' disease, PFV, and vitreous hemorrhage, but the sp
14  conditions, and the 10 most common included Coats' disease (n = 244; 40%), persistent fetal vasculat
15 ponent, have been identified as the cause of Coats plus syndrome.
16                        The classical form of Coats' disease is almost invariably isolated, unilateral
17 is CTC1 mutant and the phenotypic overlap of Coats plus with the telomeric maintenance disorders comp
18        A female with a unilateral variant of Coats' disease gave birth to a son affected by Norrie di
19 r the formation of retinal telangiectasia or Coats-like vasculopathy in patients with CRB1 mutations
20                           Here, we show that Coats plus results from mutations in CTC1, encoding cons
21                              We suggest that Coats' telangiectasis is secondary to somatic mutation i
22                       We herein describe two Coats plus patients with telomere and genomic defects; b
23                         Twenty children with Coats' disease who underwent intraoperative RetCam FA an
24 hortened telomeres in three individuals with Coats plus and an increase in spontaneous gammaH2AX-posi
25 inas of nine enucleated eyes from males with Coats' disease demonstrated in one a somatic mutation in
26                                Patients with Coats' disease diagnosed clinically, angiographically, o
27 ences in visual acuities among patients with Coats' disease who sought treatment at a tertiary care u

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。